Analysts Have Conflicting Sentiments on These Technology Companies: Plexus (PLXS) and Maxlinear (MXL)
Analysts have been eager to weigh in on the Technology sector with new ratings on Plexus (PLXS – Research Report) and Maxlinear (MXL – Research Report).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Plexus (PLXS)
In a report released today, Ruben Roy from Stifel Nicolaus maintained a Hold rating on Plexus, with a price target of $150.00. The company’s shares closed last Thursday at $149.86.
According to TipRanks.com, Roy is a top 25 analyst with an average return of
Currently, the analyst consensus on Plexus is a Moderate Buy with an average price target of $157.50, implying a 5.1% upside from current levels. In a report released today, KeyBanc also maintained a Hold rating on the stock.
See the top stocks recommended by analysts >>
Maxlinear (MXL)
In a report released today, Tore Svanberg from Stifel Nicolaus reiterated a Buy rating on Maxlinear, with a price target of $23.00.
According to TipRanks.com, Svanberg is a top 100 analyst with an average return of
Currently, the analyst consensus on Maxlinear is a Moderate Buy with an average price target of $19.80, representing a 19.0% upside. In a report issued on October 17, Benchmark Co. also maintained a Buy rating on the stock with a $25.00 price target.
Read More on PLXS:
Disclaimer & DisclosureReport an Issue
- Plexus Reports Strong Fiscal Year 2025 Results
- Plexus Earnings Call: Strong Growth Amid Sector Challenges
- Plexus: Strong Performance and Positive Outlook Justify Buy Rating
- Plexus Receives Buy Rating from David Williams Amid Strong Financial Performance and Growth Prospects
- Plexus reports Q4 adjusted EPS $2.14, consensus $1.86
